{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T12:52:19Z","timestamp":1792500739055,"version":"4.5.0"},"reference-count":64,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T00:00:00Z","timestamp":1672790400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>The protective effects of Ketogenic Diet Therapies (KDTs) on neurological diseases have been extensively studied over the past two decades. The purpose of this study was to quantitatively and qualitatively analyze the publication of KDTs in the neurological field from 2000 to 2021.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A literature search was performed on June 7th, 2022, using the search terms: ((\u201cketone\u201d OR \u201cketogenic\u201d OR \u201c*hydroxybuty*\u201d) AND (\u201cneuro*\u201d)) in the WoSCC database. Collected data were further analyzed using VOSviewer, CiteSpace and other online bibliometric websites. The annual publication volume and citation trends were summarized. The collaborations among highly cited countries, institutions, authors and journals were visualized. The co-citation analysis of highly cited references and journals were also visualized. Moreover, the research focuses and fronts were revealed by co-occurrence analysis and burst keywords detection.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 2808 publications with 88,119 citations were identified. From 2000-2021, the number of publications and citations presented rising trends. <jats:italic>The United States<\/jats:italic> was the country with an overwhelming number of publications and cited times. <jats:italic>Johns Hopkins University<\/jats:italic> was the most contributory institution. <jats:italic>Kossoff Eric H<\/jats:italic> was the author with the largest number of publications. And <jats:italic>Epilepsia<\/jats:italic> was both the largest publisher and the most frequently cited journal. The keywords of intense interest involved \u201cModified Atkins Diet\u201d, \u201cTemporal Lobe Epilepsy\u201d, \u201cAlzheimer\u2019s Disease\u201d, \u201cParkinson\u2019s Disease\u201d, \u201cCerebral Blood Flow\u201d, \u201cNeuroinflammation\u201d, \u201cOxidative Stress\u201d, \u201cMetabolism\u201d and \u201cMitochondria\u201d.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>We presented the global trend of KDTs in neurological diseases and provided important information for relevant researchers in a bibliometric way. This bibliometric study revealed that treating epilepsy, neuroprotection and functional effects of KDTs on mitochondria and oxidative stress have been the spotlight from 2000 to 2021. These have emerged as the basis for transformation from basic research to clinical application of KDTs.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2022.1066785","type":"journal-article","created":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T16:57:40Z","timestamp":1672851460000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Bibliometric analysis of global research profile on ketogenic diet therapies in neurological diseases: Beneficial diet therapies deserve more attention"],"prefix":"10.3389","volume":"13","author":[{"given":"Yinuo","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyan","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,1,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3390\/nu11102510","article-title":"Ketogenic diet and epilepsy","volume":"11","author":"U\u0142amek-Kozio\u0142","year":"2019","journal-title":"Nutrients"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1097\/01.nrl.0000160818.58821.d2","article-title":"The ketogenic diet","volume":"11","author":"Sinha","year":"2005","journal-title":"Neurologist"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2008.01821.x","article-title":"History of the ketogenic diet","volume":"49","author":"Wheless","year":"2008","journal-title":"Epilepsia"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-01209-1","article-title":"Effect of a plant-based, low-fat diet versus an animal-based, ketogenic diet on ad libitum energy intake","volume":"27","author":"Hall","year":"2021","journal-title":"Nat Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1179\/1476830514Y.0000000118","article-title":"A bibliometric study of scientific literature on the dietary therapies for epilepsy in scopus","volume":"18","author":"Morandi","year":"2015","journal-title":"Nutr Neurosci"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-018-0666-8","article-title":"Ketogenic diets for adult neurological disorders","volume":"15","author":"Mcdonald","year":"2018","journal-title":"Neurotherapeutics"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3390\/nu13072307","article-title":"Applications of ketogenic diets in patients with headache: Clinical recommendations","volume":"13","author":"Di Lorenzo","year":"2021","journal-title":"Nutrients"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1002\/mds.27390","article-title":"Low-fat versus ketogenic diet in parkinson's disease: A pilot randomized controlled trial","volume":"33","author":"Phillips","year":"2018","journal-title":"Mov Disord"},{"key":"B9","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13195-021-00783-x","article-title":"Randomized crossover trial of a modified ketogenic diet in alzheimer's disease","volume":"13","author":"Phillips","year":"2021","journal-title":"Alzheimers Res Ther"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2012.07943.x","article-title":"Stroke outcome in the ketogenic state\u2013a systematic review of the animal data","volume":"123","author":"Gibson","year":"2012","journal-title":"J Neurochem"},{"key":"B11","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/S1474-4422(17)30408-8","article-title":"Mechanisms of action for the medium-chain triglyceride ketogenic diet in neurological and metabolic disorders","volume":"17","author":"Augustin","year":"2018","journal-title":"Lancet Neurol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0307513100","article-title":"Searching for intellectual turning points: progressive knowledge domain visualization","volume":"101","author":"Chen","year":"2004","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2018.07.020","article-title":"Ketogenic diet as a metabolic therapy for mood disorders: Evidence and developments","volume":"94","author":"Brietzke","year":"2018","journal-title":"Neurosci Biobehav Rev"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s13668-019-00297-x","article-title":"Ketogenic diet: an endocrinologist perspective","volume":"8","author":"Kuchkuntla","year":"2019","journal-title":"Curr Nutr Rep"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21228767","article-title":"Effects of ketone bodies on brain metabolism and function in neurodegenerative diseases","volume":"21","author":"Jensen","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3390\/nu13072197","article-title":"Beneficial effects of exogenous ketogenic supplements on aging processes and age-related neurodegenerative diseases","volume":"13","author":"Kov\u00e1cs","year":"2021","journal-title":"Nutrients"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2019.08.032","article-title":"Modified Mediterranean-ketogenic diet modulates gut microbiome and short-chain fatty acids in association with alzheimer's disease markers in subjects with mild cognitive impairment","volume":"47","author":"Nagpal","year":"2019","journal-title":"EBioMedicine"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1002\/alz.12206","article-title":"A ketogenic drink improves cognition in mild cognitive impairment: Results of a 6-month RCT","volume":"17","author":"Fortier","year":"2021","journal-title":"Alzheimers Dement"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2018.00086","article-title":"Ketogenic diet improves brain ischemic tolerance and inhibits NLRP3 inflammasome activation by preventing Drp1-mediated mitochondrial fission and endoplasmic reticulum stress","volume":"11","author":"Guo","year":"2018","journal-title":"Front Mol Neurosci"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/jcbfm.2008.79","article-title":"Neuroprotection in diet-induced ketotic rat brain after focal ischemia","volume":"28","author":"Puchowicz","year":"2008","journal-title":"J Cereb Blood Flow Metab"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2018.00015","article-title":"How can a ketogenic diet improve motor function","volume":"11","author":"Veyrat-Durebex","year":"2018","journal-title":"Front Mol Neurosci"},{"key":"B22","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1172\/JCI18797","article-title":"D-beta-hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson disease","volume":"112","author":"Tieu","year":"2003","journal-title":"J Clin Invest"},{"key":"B23","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1471-2202-7-29","article-title":"A ketogenic diet as a potential novel therapeutic intervention in amyotrophic lateral sclerosis","volume":"7","author":"Zhao","year":"2006","journal-title":"BMC Neurosci"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2009.02.038","article-title":"Improvement in motor and exploratory behavior in rett syndrome mice with restricted ketogenic and standard diets","volume":"15","author":"Mantis","year":"2009","journal-title":"Epilepsy Behav"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2013.01.046","article-title":"A ketogenic diet improves motor performance but does not affect \u03b2-amyloid levels in a mouse model of alzheimer's disease","volume":"1505","author":"Beckett","year":"2013","journal-title":"Brain Res"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0078765","article-title":"Ketogenic diet improves forelimb motor function after spinal cord injury in rodents","volume":"8","author":"Streijger","year":"2013","journal-title":"PloS One"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.12.024","article-title":"Early motor-behavioral outcome of ischemic stroke with ketogenic diet preconditioning: Interventional animal study","volume":"28","author":"Shaafi","year":"2019","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2017.00120","article-title":"The changing landscape of neuroscience research, 2006-2015: A bibliometric study","volume":"11","author":"Yeung","year":"2017","journal-title":"Front Neurosci"},{"key":"B29","doi-asserted-by":"publisher","first-page":"186","DOI":"10.3109\/07853890.2015.1007520","article-title":"Rapid prototyping-assisted maxillofacial reconstruction","volume":"47","author":"Peng","year":"2015","journal-title":"Ann Med"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000012386","article-title":"Feasibility and biological activity of a Ketogenic\/Intermittent-fasting diet in patients with glioma","volume":"97","author":"Schreck","year":"2021","journal-title":"Neurology"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1093\/nop\/npv010","article-title":"Glycemic modulation in neuro-oncology: experience and future directions using a modified Atkins diet for high-grade brain tumors","volume":"2","author":"Strowd","year":"2015","journal-title":"Neurooncol Pract"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-8749.2010.03744.x","article-title":"Doose syndrome (myoclonic-astatic epilepsy): 40 years of progress","volume":"52","author":"Kelley","year":"2010","journal-title":"Dev Med Child Neurol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1002\/epi4.12225","article-title":"Optimal clinical management of children receiving dietary therapies for epilepsy: Updated recommendations of the international ketogenic diet study group","volume":"3","author":"Kossoff","year":"2018","journal-title":"Epilepsia Open"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2008.01765.x","article-title":"Optimal clinical management of children receiving the ketogenic diet: recommendations of the international ketogenic diet study group","volume":"50","author":"Kossoff","year":"2009","journal-title":"Epilepsia"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.pediatrneurol.2017.10.018","article-title":"Ketogenic diet therapy in infants: Efficacy and tolerability","volume":"82","author":"Wirrell","year":"2018","journal-title":"Pediatr Neurol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1111\/ane.12592","article-title":"A randomized controlled trial of the ketogenic diet in refractory childhood epilepsy","volume":"135","author":"Lambrechts","year":"2017","journal-title":"Acta Neurol Scand"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1111\/epi.16543","article-title":"Use of ketogenic diet therapy in infants with epilepsy: A systematic review and meta-analysis","volume":"61","author":"Lyons","year":"2020","journal-title":"Epilepsia"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.97.10.5440","article-title":"D-beta-hydroxybutyrate protects neurons in models of alzheimer's and parkinson's disease","volume":"97","author":"Kashiwaya","year":"2000","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.13979","article-title":"Novel ketone body therapy for managing alzheimer's disease: An editorial highlight for effects of a dietary ketone ester on hippocampal glycolytic and tricarboxylic acid cycle intermediates and amino acids in a 3xTgAD mouse model of alzheimer's disease","volume":"141","author":"Puchowicz","year":"2017","journal-title":"J Neurochem"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2015.11.018","article-title":"Ketones block amyloid entry and improve cognition in an alzheimer's model","volume":"39","author":"Yin","year":"2016","journal-title":"Neurobiol Aging"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2020.06.021","article-title":"ERGO2: A prospective, randomized trial of calorie-restricted ketogenic diet and fasting in addition to reirradiation for malignant glioma","volume":"108","author":"Voss","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0036197","article-title":"The ketogenic diet is an effective adjuvant to radiation therapy for the treatment of malignant glioma","volume":"7","author":"Abdelwahab","year":"2012","journal-title":"PloS One"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2019.4942","article-title":"A ketogenic diet attenuates proliferation and stemness of glioma stem\u2212like cells by altering metabolism resulting in increased ROS production","volume":"56","author":"Ji","year":"2020","journal-title":"Int J Oncol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1254\/jjp.89.36","article-title":"Beta-hydroxybutyrate, a cerebral function improving agent, protects rat brain against ischemic damage caused by permanent and transient focal cerebral ischemia","volume":"89","author":"Suzuki","year":"2002","journal-title":"Jpn J Pharmacol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.2147\/CIA.S95362","article-title":"Benefits of use, and tolerance of, medium-chain triglyceride medical food in the management of Japanese patients with alzheimer's disease: a prospective, open-label pilot study","volume":"11","author":"Ohnuma","year":"2016","journal-title":"Clin Interv Aging"},{"key":"B46","article-title":"[A clinical trial of ketogenic diet in patients with acute spinal cord injury: safety and feasibility]","volume":"34","author":"Guo","year":"2014","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"B47","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1212\/01.wnl.0000216108.57529.b1","article-title":"Treatment of Parkinson disease with diet-induced hyperketonemia: a feasibility study","volume":"66","author":"Jabre","year":"2006","journal-title":"Neurology"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1177\/08830738030180011801","article-title":"Ketogenic diet in rett syndrome","volume":"18","author":"Liebhaber","year":"2003","journal-title":"J Child Neurol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/j.1528-1167.2007.00915.x","article-title":"Anticonvulsant mechanisms of the ketogenic diet","volume":"48","author":"Bough","year":"2007","journal-title":"Epilepsia"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1126\/science.1227166","article-title":"Suppression of oxidative stress by \u03b2-hydroxybutyrate, an endogenous histone deacetylase inhibitor","volume":"339","author":"Shimazu","year":"2013","journal-title":"Science"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1021\/acschemneuro.1c00046","article-title":"Rational application of \u03b2-hydroxybutyrate attenuates ischemic stroke by suppressing oxidative stress and mitochondrial-dependent apoptosis via activation of the Erk\/CREB\/eNOS pathway","volume":"12","author":"Li","year":"2021","journal-title":"ACS Chem Neurosci"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.118.020586","article-title":"Imaging the effects of \u03b2-hydroxybutyrate on peri-infarct neurovascular function and metabolism","volume":"49","author":"Bazzigaluppi","year":"2018","journal-title":"Stroke"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2019.09.015","article-title":"Modified ketogenic diet is associated with improved cerebrospinal fluid biomarker profile, cerebral perfusion, and cerebral ketone body uptake in older adults at risk for alzheimer's disease: a pilot study","volume":"86","author":"Neth","year":"2020","journal-title":"Neurobiol Aging"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2018.07.009","article-title":"Changes in regional cerebral blood flow associated with a 45 day course of the ketogenic agent, caprylidene, in patients with mild to moderate alzheimer's disease: Results of a randomized, double-blinded, pilot study","volume":"111","author":"Torosyan","year":"2018","journal-title":"Exp Gerontol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"6670","DOI":"10.1038\/s41598-018-25190-5","article-title":"Ketogenic diet enhances neurovascular function with altered gut microbiome in young healthy mice","volume":"8","author":"Ma","year":"2018","journal-title":"Sci Rep"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3804","article-title":"The ketone metabolite \u03b2-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease","volume":"21","author":"Youm","year":"2015","journal-title":"Nat Med"},{"key":"B57","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s12974-020-01948-5","article-title":"\u03b2-hydroxybutyrate inhibits inflammasome activation to attenuate alzheimer's disease pathology","volume":"17","author":"Shippy","year":"2020","journal-title":"J Neuroinflamm"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2018.00263","article-title":"Ketogenic diet modulates NAD-dependent enzymes and reduces DNA damage in hippocampus","volume":"12","author":"Elamin","year":"2018","journal-title":"Front Cell Neurosci"},{"key":"B59","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.expneurol.2007.12.029","article-title":"Antioxidant capacity contributes to protection of ketone bodies against oxidative damage induced during hypoglycemic conditions","volume":"211","author":"Haces","year":"2008","journal-title":"Exp Neurol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00717.2006","article-title":"A high-fat, ketogenic diet induces a unique metabolic state in mice","volume":"292","author":"Kennedy","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B61","doi-asserted-by":"publisher","first-page":"4826","DOI":"10.1038\/s41467-021-25157-7","article-title":"NEK1-mediated retromer trafficking promotes blood-brain barrier integrity by regulating glucose metabolism and RIPK1 activation","volume":"12","author":"Wang","year":"2021","journal-title":"Nat Commun"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21030934","article-title":"Ketone bodies promote amyloid-\u03b2 clearance in a human in vitro blood-brain barrier model","volume":"21","author":"Versele","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-005-5518-0","article-title":"Cerebral ketone body metabolism","volume":"28","author":"Morris","year":"2005","journal-title":"J Inherit Metab Dis"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1023\/B:PHAM.0000048189.79606.6e","article-title":"Effects of pluronic P85 on GLUT1 and MCT1 transporters in the blood-brain barrier","volume":"21","author":"Batrakova","year":"2004","journal-title":"Pharm Res"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.1066785\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T16:57:44Z","timestamp":1672851464000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.1066785\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,4]]},"references-count":64,"alternative-id":["10.3389\/fendo.2022.1066785"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.1066785","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,4]]},"article-number":"1066785"}}